Johanniskraut Tee

Hypericum perforatum, the active ingredient in Johanniskraut Tee, is a herbal presented as a herbal tea for oral use. It is traditionally used to support mood balance and may be considered for mild to moderate depressive symptoms in adults.

GNH USA supplies Johanniskraut Tee as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Hypericum perforatum, administered as Johanniskraut Tee, is used primarily for mood‑related conditions.

- Mild to moderate depressive symptoms: may help improve mood and emotional wellbeing in adults. - Seasonal affective disorder: may provide relief of low mood during seasonal changes. - Mild anxiety: may support emotional balance and reduce occasional nervousness.

Common Side Effects: - Gastrointestinal discomfort: mild nausea or stomach upset. - Photosensitivity: increased skin sensitivity to sunlight. - Dizziness or light‑headedness. - Dry mouth or mild headache.

Serious or Rare Side Effects: - Serotonin syndrome when combined with serotonergic drugs. - Severe allergic reactions, including rash or swelling. - Induction of liver enzymes leading to clinically significant drug interactions.

Hypericum perforatum should be used with caution in specific populations and situations. - Pregnancy: safety not established; avoid use unless advised by a healthcare professional. - Breastfeeding: insufficient data; consider alternatives. - Bipolar disorder: may trigger manic episodes; monitor closely. - Photosensitivity: limit exposure to strong sunlight and use protective clothing. - Drug interactions: consult a physician before combining with other medications. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct light.

Hypericum perforatum can affect the metabolism of several medicines.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): increased serotonergic activity. - Oral anticoagulants (e.g., warfarin): reduced anticoagulant effect.

Moderate Interactions (Monitor Closely): - Antiretroviral agents (e.g., protease inhibitors): decreased plasma concentrations. - Immunosuppressants (e.g., cyclosporine): reduced therapeutic levels.